| C06921 |
Clorazepate; Clorazepic acid |
(P) unclassified |
| C07480 |
Theobromine; 3,7-Dimethylxanthine |
(P) unclassified |
| D00020 |
Tryptophan (USP/INN); L-Tryptophan (JP19) |
(P) unclassified |
| D00058 |
gamma-Aminobutyric acid (JAN); Gammalon (TN) |
(P) unclassified |
| D00136 |
Haloperidol (JP19/USP/INN); Haldol (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00140 |
Erythromycin (JP19/USP/INN); Akne-mycin (TN); Eryc (TN); Erygel (TN); Pce (TN); Staticin (TN); T-stat (TN) |
(P) unclassified |
| D00199 |
Ajmaline (JP19) |
(P) CYP inhibition: CYP2D6 |
| D00222 |
Acyclovir (USP); Aciclovir (JP19/INN); Sitavig (TN); Zovirax (TN) |
(P) unclassified |
| D00225 |
Alprazolam (JP19/USP/INN); Xanax (TN) |
(P) unclassified |
| D00227 |
Aminophylline (USP/INN); Somophyllin (TN); Theophylline ethylenediamine (TN) |
(P) unclassified |
| D00228 |
Amoxapine (JP19/USP/INN); Asendin (TN) |
(P) CYP inhibition: CYP2D6 |
| D00235 |
Atenolol (JP19/USP/INN); Tenormin (TN) |
(P) CYP inhibition: CYP2D6 |
| D00246 |
Budesonide (JP19/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) CYP inhibition: CYP3A4 |
| D00252 |
Carbamazepine (JP19/USP/INN); Equetro (TN); Tegretol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00255 |
Carvedilol (JP19/USP/INN); Artist (TN); Coreg (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00267 |
Chlordiazepoxide (JP19/USP/INN); Libritabs (TN) |
(P) unclassified |
| D00280 |
Clonazepam (JP19/USP/INN); Klonopin (TN) |
(P) unclassified |
| D00283 |
Clozapine (JAN/USP/INN); Clozaril (TN) |
(P) CYP inhibition: CYP3A4 |
| D00293 |
Diazepam (JP19/USP/INN); Diastat (TN); Valium (TN) |
(P) CYP inhibition: CYP3A4 |
| D00298 |
Digoxin (JP19/USP); Lanoxicaps (TN); Lanoxin (TN) |
(P) unclassified |
| D00303 |
Disopyramide (JP19/USAN/INN); Rythmodan P (TN) |
(P) CYP inhibition: CYP3A4 |
| D00304 |
Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
(P) unclassified |
| D00311 |
Estazolam (JP19/USP/INN); ProSom (TN) |
(P) unclassified |
| D00319 |
Felodipine (JP19/USP/INN); Plendil (TN) |
(P) CYP inhibition: CYP3A4 |
| D00320 |
Fentanyl (JAN/USP/INN); Duragesic (TN); Subsys (TN) |
(P) CYP inhibition: CYP3A4 |
| D00326 |
Fluoxetine (USAN/INN); Fluoxetine (TN) |
(P) CYP inhibition: CYP2D6 |
| D00329 |
Flurazepam (JAN/INN); Insumin (TN) |
(P) unclassified |
| D00338 |
Halazepam (USAN/INN); Paxipam (TN) |
(P) unclassified |
| D00349 |
Isradipine (USP/INN); Dynacirc (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP19/USP); Itrizole (TN); Sporanox (TN) |
(P) CYP inhibition: CYP3A4 |
| D00354 |
Lamotrigine (JAN/USP/INN); Lamictal (TN) |
(P) unclassified |
| D00358 |
Lidocaine (JP19/USP/INN); Dentipatch (TN); Xylocaine (TN) |
(P) CYP inhibition: CYP3A4 |
| D00364 |
Loratadine (JAN/USP/INN); Claritin (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00365 |
Lorazepam (JP19/USP/INN); Ativan (TN) |
(P) unclassified |
| D00368 |
Mebendazole (JAN/USP/INN); Vermox (TN) |
(P) unclassified |
| D00370 |
Temazepam (USP/INN); Restoril (TN) |
(P) unclassified |
| D00371 |
Theophylline (JP19); Elixophyllin (TN); Quibron-t (TN); Theo-24 (TN); Theodur G (TN); Theolair (TN); Uniphyl (TN) |
(P) unclassified |
| D00375 |
Mephenytoin (USP/INN); Mesantoin (TN) |
(P) unclassified |
| D00378 |
Timolol (USAN); Timolol hemihydrate; Betimol (TN) |
(P) CYP inhibition: CYP2D6 |
| D00387 |
Triazolam (JP19/USP/INN); Halcion (TN) |
(P) CYP inhibition: CYP3A4 |
| D00392 |
Trimethadione (JP19/INN); Tridione (TN) |
(P) unclassified |
| D00394 |
Trimipramine (USAN/INN) |
(P) unclassified |
| D00398 |
Valacyclovir hydrochloride (USP); Valaciclovir hydrochloride (JP19); Valtrex (TN) |
(P) unclassified |
| D00399 |
Valproic acid (USP); Depakene (TN) |
(P) unclassified |
| D00404 |
Methsuximide (USP); Mesuximide (INN); Celontin (TN) |
(P) unclassified |
| D00415 |
Zolmitriptan (JAN/USP/INN); Zomig (TN) |
(P) unclassified |
| D00426 |
Risperidone (JP19/USP/INN); Risperdal (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00432 |
Nadolol (JP19/USP/INN); Corgard (TN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00437 |
Nifedipine (JP19/USP/INN); Adalat (TN); Afeditab CR (TN); Procardia (TN) |
(P) CYP inhibition: CYP3A4 |
| D00438 |
Nimodipine (USP/INN); Nimotop (TN); Nymalize (TN) |
(P) CYP inhibition: CYP3A4 |
| D00457 |
Quazepam (JAN/USP/INN); Doral (TN) |
(P) CYP inhibition: CYP3A4 |
| D00458 |
Quetiapine fumarate (JP19/USP); Seroquel (TN) |
(P) CYP inhibition: CYP3A4 |
| D00464 |
Oxazepam (JAN/USP/INN); Serax (TN) |
(P) unclassified |
| D00470 |
Prazepam (JP19/USAN/INN); Centrax (TN) |
(P) unclassified |
| D00471 |
Praziquantel (JAN/USP/INN); Biltricide (TN) |
(P) CYP inhibition: CYP3A4 |
| D00472 |
Prednisolone (JP19/USP/INN); Delta-cortef (TN) |
(P) unclassified |
| D00474 |
Primidone (JP19/USP/INN); Mysoline (TN) |
(P) unclassified |
| D00477 |
Procainamide hydrochloride (JP19/USP); Procan SR (TN); Procanbid (TN); Pronestyl (TN) |
(P) unclassified |
| D00483 |
Propranolol hydrochloride (JP19/USP); Inderal (TN); Innopran XL (TN) |
(P) CYP inhibition: CYP2D6 |
| D00484 |
Protriptyline hydrochloride (USP); Vivactil (TN) |
(P) unclassified |
| D00495 |
Paramethadione (INN); Paradione (TN) |
(P) unclassified |
| D00501 |
Pentoxifylline (JAN/USP/INN); Pentoxil (TN); Trental (TN) |
(P) unclassified |
| D00504 |
Phenacemide (JAN/INN); Phenurone (TN) |
(P) unclassified |
| D00505 |
Phenelzine sulfate (USP); Nardil (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP19/USP/INN); Luminal (TN) |
(P) unclassified |
| D00508 |
Phensuximide (USP/INN); Milontin (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP19/USP/INN); Dilantin (TN) |
(P) unclassified |
| D00513 |
Pindolol (JP19/USP/INN); Blocklin-L (TN); Carvisken (TN); Visken (TN) |
(P) CYP inhibition: CYP2D6 |
| D00520 |
Dimenhydrinate (JP19/USP/INN); Dramamine (TN) |
(P) unclassified |
| D00528 |
Caffeine (USP); Anhydrous caffeine (JP19); Anhydrous caffeine (TN); Respia (TN) |
(P) unclassified |
| D00531 |
Nitrazepam (JP19/USAN/INN); Benzalin (TN); Nitrazepam (TN) |
(P) unclassified |
| D00533 |
Oxcarbazepine (JAN/USP/INN); Oxtellar (TN); Trileptal (TN) |
(P) unclassified |
| D00535 |
Vigabatrin (JAN/USP/INN); Sabril (TN) |
(P) unclassified |
| D00536 |
Felbamate (USPINN); Felbatol (TN) |
(P) unclassified |
| D00537 |
Topiramate (JAN/USP/INN); Topamax (TN); Trokendi xr (TN) |
(P) CYP inhibition: CYP3A4 |
| D00538 |
Zonisamide (JP19/USP/INN); Excegran (TN) |
(P) unclassified |
| D00539 |
Ethosuximide (JP19/USP/INN); Zarontin (TN) |
(P) CYP inhibition: CYP3A4 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) CYP inhibition: CYP3A4 |
| D00553 |
Prilocaine (USP/INN); Propitocaine (JAN) |
(P) unclassified |
| D00559 |
Pramipexole dihydrochloride (USP); Pramipexole hydrochloride hydrate (JAN); Pramipexole dihydrochloride monohydrate; Mirapex (TN) |
(P) unclassified |
| D00563 |
Mirtazapine (JAN/USP/INN); Remeron (TN); Reflex (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) unclassified |
| D00570 |
Colchicine (JP19/USP) |
(CI,P) CYP inhibition: CYP3A4 |
| D00597 |
Acebutolol hydrochloride (JP19/USP); Sectral (TN) |
(P) unclassified |
| D00598 |
Betaxolol hydrochloride (JP19/USP); Betoptic (TN); Kerlone (TN) |
(P) unclassified |
| D00599 |
Carteolol hydrochloride (JP19/USP); Cartrol (TN); Ocupress (TN) |
(P) CYP inhibition: CYP2D6 |
| D00600 |
Labetalol hydrochloride (JP19/USP); Normodyne (TN); Trandate (TN) |
(P) unclassified |
| D00601 |
Metoprolol tartrate (JP19/USP); Lopressor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00602 |
Penbutolol sulfate (JP19/USP); Levatol (TN) |
(P) unclassified |
| D00603 |
Timolol maleate (JP19/USP); Blocadren (TN); Istalol (TN); Timoptic (TN) |
(P) CYP inhibition: CYP2D6 |
| D00606 |
Guanfacine hydrochloride (JAN/USP); Intuniv (TN); Tenex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00615 |
Amlodipine besylate (USP); Amlodipine besilate (JP19); Norvasc (TN) |
(P) CYP inhibition: CYP3A4 |
| D00616 |
Diltiazem hydrochloride (JP19/USP); Cardizem (TN); Cartia XT (TN); Dilacor XR (TN); Dilt-CD (TN) |
(P) CYP inhibition: CYP3A4 |
| D00617 |
Nicardipine hydrochloride (JP19/USAN); Cardene (TN) |
(P) CYP inhibition: CYP3A4 |
| D00618 |
Nisoldipine (JAN/USAN/INN); Sular (TN) |
(P) CYP inhibition: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP19/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) CYP inhibition: CYP3A4 |
| D00629 |
Nitrendipine (JP19/USAN/INN); Baypress (TN) |
(P) CYP inhibition: CYP3A4 |
| D00631 |
Bepridil hydrochloride (USAN); Bepridil hydrochloride hydrate (JAN); Vascor (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00634 |
Bisoprolol fumarate (JP19/USP); Zebeta (TN) |
(P) unclassified |
| D00635 |
Metoprolol succinate (USP); Toprol XL (TN) |
(P) CYP inhibition: CYP2D6 |
| D00636 |
Amiodarone hydrochloride (JP19/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) CYP inhibition: CYP3A4 |
| D00637 |
Disopyramide phosphate (JAN/USP); Norpace (TN) |
(P) CYP inhibition: CYP3A4 |
| D00638 |
Flecainide acetate (JP19/USP); Tambocor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00639 |
Mexiletine hydrochloride (JP19/USP); Mexitil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00640 |
Propafenone hydrochloride (JP19/USP); Rythmol (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00642 |
Quinidine gluconate (USP); Quinaglute (TN) |
(P) CYP inhibition: CYP3A4 |
| D00643 |
Quinidine polygalacturonate; Cardioquin (TN) |
(P) CYP inhibition: CYP3A4 |
| D00644 |
Esmolol hydrochloride (JAN/USP); Brevibloc (TN) |
(P) unclassified |
| D00645 |
Bretylium tosylate (USP); Bretylium tosilate (INN); Bretylol (TN) |
(P) unclassified |
| D00647 |
Dofetilide (JAN/USP/INN); Tikosyn (TN) |
(P) unclassified |
| D00648 |
Ibutilide fumarate (USP); Corvert (TN) |
(P) unclassified |
| D00661 |
Cevimeline hydrochloride (USAN); Cevimeline hydrochloride hydrate (JAN); Evoxac (TN); Saligren (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00670 |
Donepezil hydrochloride (JP19/USP); Aricept (TN) |
(P) CYP inhibition: CYP3A4 |
| D00672 |
Hydroxyzine hydrochloride (JP19/USP); Hydroxyzine dihydrochloride; Atarax (TN); Vistaril (TN) |
(P) unclassified |
| D00680 |
Methylergonovine maleate (USP); Methylergometrine maleate (JP19); Methergine (TN) |
(P) CYP inhibition: CYP3A4 |
| D00687 |
Salmeterol xinafoate (JAN/USP); Serevent (TN) |
(P) CYP inhibition: CYP3A4 |
| D00691 |
Dyphylline (USP); Diprophylline (JAN/INN); Lufyllin (TN) |
(P) unclassified |
| D00693 |
Chlordiazepoxide hydrochloride (JAN/USP); Librium (TN) |
(P) unclassified |
| D00694 |
Clorazepate dipotassium (JP19/USP); Tranxene (TN) |
(P) unclassified |
| D00695 |
Flurazepam hydrochloride (USP); Flurazepam dihydrochloride; Dalmane (TN) |
(P) unclassified |
| D00696 |
Midazolam hydrochloride (USAN); Versed (TN) |
(P) CYP inhibition: CYP3A4 |
| D00700 |
Mephobarbital (JAN/USP); Methylphenobarbital (INN); Mebaral (TN) |
(P) unclassified |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00708 |
Ethotoin (JAN/USP/INN); Accenon (TN); Peganone (TN) |
(P) unclassified |
| D00709 |
Levetiracetam (JP19/USP/INN); Keppra (TN); E keppra (TN) |
(P) unclassified |
| D00710 |
Valproate sodium (USAN); Sodium valproate (JP19); Depakene (TN); Selenica (TN) |
(P) unclassified |
| D00722 |
Oxybutynin chloride (USP); Oxybutynin hydrochloride (JP19); Ditropan (TN); Gelnique (TN) |
(P) CYP inhibition: CYP3A4 |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) CYP inhibition: CYP3A4 |
| D00765 |
Rocuronium bromide (JAN/USP/INN); Zemuron (TN) |
(P) unclassified |
| D00776 |
Tizanidine hydrochloride (JP19/USP); Zanaflex (TN) |
(P) unclassified |
| D00785 |
Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00809 |
Amitriptyline hydrochloride (JP19/USP); Elavil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00811 |
Clomipramine hydrochloride (JP19/USP); Anafranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00812 |
Desipramine hydrochloride (JAN/USP); Norpramin (TN) |
(P) unclassified |
| D00814 |
Doxepin hydrochloride (USP); Sinequan (TN); Zonalon (TN) |
(P) CYP inhibition: CYP2D6 |
| D00815 |
Imipramine hydrochloride (JP19/USP); Tofranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00816 |
Nortriptyline hydrochloride (JP19/USP/INN); Pamelor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00817 |
Bupropion hydrochloride (JAN/USP); Wellbutrin (TN); Zyban (TN) |
(P) unclassified |
| D00818 |
Maprotiline hydrochloride (JP19/USP); Ludiomil (TN) |
(P) CYP inhibition: CYP2D6 |
| D00819 |
Nefazodone hydrochloride (USP); Serzone (TN) |
(P) unclassified |
| D00820 |
Trazodone hydrochloride (JAN/USP); Desyrel (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00821 |
Venlafaxine hydrochloride (JAN/USP); Effexor (TN) |
(P) CYP inhibition: CYP2D6 |
| D00822 |
Citalopram hydrobromide (USP); Celexa (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D00823 |
Fluoxetine hydrochloride (JAN/USP); Prozac (TN); Sarafem (TN) |
(P) CYP inhibition: CYP2D6 |
| D00824 |
Fluvoxamine maleate (JP19/USP); Luvox (TN) |
(P) CYP inhibition: CYP2D6 |
| D00825 |
Sertraline hydrochloride (JAN/USP); Zoloft (TN) |
(P) CYP inhibition: CYP3A4 |
| D00826 |
Tranylcypromine sulfate (USP); Parnate (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP19/USP); Lariam (TN) |
(P) unclassified |
| D00836 |
Buprenorphine hydrochloride (JP19/USP); Buprenex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00848 |
Dextromethorphan hydrobromide (USP); Dextromethorphan hydrobromide hydrate (JP19); Benylin DM (TN) |
(P) CYP inhibition: CYP2D6 |
| D00851 |
Erythromycin estolate (USP); Erythromycin estorate (JAN); Ilosone (TN) |
(P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) CYP inhibition: CYP3A4 |
| D00944 |
Metformin hydrochloride (JP19/USP); Glucophage (TN) |
(P) unclassified |
| D00964 |
Letrozole (JAN/USP/INN); Femara (TN) |
(P) CYP inhibition: CYP3A4 |
| D01025 |
Levobunolol hydrochloride (JAN/USP); Betagan (TN) |
(P) unclassified |
| D01026 |
Sotalol hydrochloride (JAN/USP); Betapace (TN); Sorine (TN) |
(P) unclassified |
| D01041 |
Sparteine (INN) |
(P) CYP inhibition: CYP2D6 |
| D01061 |
Irinotecan hydrochloride (USP); Irinotecan hydrochloride hydrate (JP19); Irinotecan hydrochloride trihydrate; CPT 11; CPT-11; Campto (TN); Camptosar (TN); Onivyde (TN) |
(P) unclassified |
| D01096 |
Hydroxyzine pamoate (JP19/USP); Atarax-P (TN); Vistaril pamoate (TN) |
(P) unclassified |
| D01104 |
Barnidipine hydrochloride (JAN); Hypoca (TN) |
(P) CYP inhibition: CYP3A4 |
| D01107 |
Milnacipran hydrochloride (JAN/USAN); Savella (TN); Toledomin (TN) |
(P) unclassified |
| D01110 |
Melitracen hydrochloride (JAN/USAN) |
(P) unclassified |
| D01115 |
Eplerenone (JP19/USAN/INN); Inspra (TN) |
(P) CYP inhibition: CYP3A4 |
| D01144 |
Prulifloxacin (JAN/INN); Sword (TN) |
(P) unclassified |
| D01145 |
Azelnidipine (JP19/INN); Calblock (TN) |
(P) CYP inhibition: CYP3A4 |
| D01146 |
Iguratimod (JAN/INN) |
(P) unclassified |
| D01164 |
Aripiprazole (JP19/USP/INN); Abilify (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01167 |
Magnesium oxide (JP19/USP); Magmitt (TN) |
(P) unclassified |
| D01172 |
Diphenylpyraline hydrochloride (JAN); Hispril (TN); Vena (TN) |
(P) unclassified |
| D01173 |
Cilnidipine (JP19/INN); Atelec (TN) |
(P) CYP inhibition: CYP3A4 |
| D01176 |
Blonanserin (JP19/INN); AD 5423 |
(CI,P) CYP inhibition: CYP3A4 |
| D01179 |
Duloxetine hydrochloride (JAN/USP); Cymbalta (TN); Yentreve (TN) |
(P) unclassified |
| D01182 |
Alprenolol hydrochloride (JP19/USAN); Regletin (TN) |
(P) CYP inhibition: CYP2D6 |
| D01190 |
Ethylphenacemide (JAN); Pheneturide (INN) |
(P) unclassified |
| D01213 |
Tolvaptan (JP19/USAN/INN); Samsca (TN) |
(P) CYP inhibition: CYP3A4 |
| D01230 |
Flunitrazepam (JP19/USAN/INN); Rohypnol (TN) |
(P) unclassified |
| D01239 |
Prednisolone sodium succinate (JP19/USP); Kohakusanin (TN) |
(P) unclassified |
| D01240 |
Deslanoside (JP19/USP/INN); Cedilanid-d (TN) |
(P) unclassified |
| D01243 |
Prilocaine hydrochloride (USP); Propitocaine hydrochloride (JAN); Citanest (TN) |
(P) unclassified |
| D01245 |
Bromazepam (JP19/USAN/INN); Lectopam (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) CYP inhibition: CYP3A4 |
| D01254 |
Tofisopam (JP19/INN); Emandaxin (TN) |
(P) unclassified |
| D01268 |
Cloxazolam (JP19/INN); Sepazon (TN) |
(P) unclassified |
| D01278 |
Oxazolam (JP19/INN); Serenal (TN) |
(P) unclassified |
| D01279 |
Flutoprazepam (JAN/INN); Restas (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP19); Athrombin-K (TN) |
(P) unclassified |
| D01285 |
Lofepramine hydrochloride (JAN/USAN); Amplit (TN) |
(P) unclassified |
| D01286 |
Flutazolam (JAN/INN); Coreminal (TN) |
(P) unclassified |
| D01287 |
Levobupivacaine hydrochloride (JAN/USAN); Chirocaine (TN) |
(P) CYP inhibition: CYP3A4 |
| D01292 |
Medazepam (JP19/INN); Pamnace (TN) |
(P) unclassified |
| D01293 |
Ethyl loflazepate (JP19/INN); Meilax (TN) |
(P) CYP inhibition: CYP3A4 |
| D01303 |
Flunarizine hydrochloride (JAN/USAN) |
(P) CYP inhibition: CYP2D6 |
| D01314 |
Dibenzepin hydrochloride (JAN/USAN) |
(P) unclassified |
| D01316 |
Mexazolam (JAN/INN); Melex (TN) |
(P) CYP inhibition: CYP3A4 |
| D01326 |
Aprindine hydrochloride (JP19/USAN); Aspenon (TN) |
(P) CYP inhibition: CYP2D6 |
| D01328 |
Clotiazepam (JP19/INN); Rize (TN) |
(P) unclassified |
| D01354 |
Fludiazepam (JP19/INN); Erispan (TN) |
(P) unclassified |
| D01358 |
Mianserin hydrochloride (JAN/USAN); Tetramide (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01361 |
Erythromycin ethylsuccinate (JP19/USP); E.E.S. (TN); Eryped (TN); Erythrocin W (TN) |
(P) unclassified |
| D01372 |
Zopiclone (JP19/INN); Amoban (TN) |
(P) CYP inhibition: CYP3A4 |
| D01382 |
Metharbital (JAN/INN); Gemonil (TN) |
(P) unclassified |
| D01399 |
Fentanyl citrate (JP19/USP); Abstral (TN); Fentora (TN); Lazanda (TN); Oralet (TN) |
(P) CYP inhibition: CYP3A4 |
| D01408 |
Flurazepam hydrochloride (JP19); Flurazepam monohydrochloride; Dalmate (TN) |
(P) unclassified |
| D01418 |
Tamibarotene (JAN/USAN/INN); Am 80; Amnoid (TN) |
(P) CYP inhibition: CYP3A4 |
| D01453 |
Caffeine hydrate (JP19); Caffeine monohydrate |
(P) unclassified |
| D01454 |
Bupranolol hydrochloride (JP19) |
(P) unclassified |
| D01455 |
Cifenline succinate (USAN); Cibenzoline succinate (JP19); Cibenol (TN); Cipralan (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01471 |
Esatenolol (JAN/INN); (S)-Atenolol |
(P) unclassified |
| D01477 |
Opipramol hydrochloride (JAN/USAN); Insidon (TN) |
(P) unclassified |
| D01492 |
Bucumolol hydrochloride (JP19) |
(P) unclassified |
| D01504 |
Bufetolol hydrochloride (JP19); Adobiol (TN) |
(P) unclassified |
| D01512 |
Befunolol hydrochloride (JAN); Bentos (TN) |
(P) unclassified |
| D01514 |
Etizolam (JP19/INN); Sedekopan (TN) |
(P) CYP inhibition: CYP3A4 |
| D01546 |
Dothiepin hydrochloride (USAN); Dosulepin hydrochloride (JAN); Prothiaden (TN) |
(P) CYP inhibition: CYP2D6 |
| D01553 |
Manidipine hydrochloride (JP19); Manidipine dihydrochloride; Calslot (TN) |
(P) CYP inhibition: CYP3A4 |
| D01554 |
Pilsicainide hydrochloride hydrate (JP19); Pilsicainide hydrochloride; SUN 1165 (TN); Sunrythm (TN) |
(P) unclassified |
| D01562 |
Aranidipine (JAN/INN); Sapresta (TN) |
(P) CYP inhibition: CYP3A4 |
| D01564 |
Rilmazafone hydrochloride hydrate (JP19); Rilmazafone hydrochloride dihydrate; Rilmazafone hydrochloride; Rhythmy (TN) |
(P) CYP inhibition: CYP3A4 |
| D01593 |
Nimetazepam (JAN/INN); Erimin (TN) |
(P) unclassified |
| D01604 |
Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochloride; NZ 105 ethanolate; Landel (TN) |
(P) unclassified |
| D01627 |
Diphenylpyraline teoclate (JAN); Piprinhydrinate; Plokon (TN) |
(P) unclassified |
| D01630 |
Propentofylline (JAN/INN) |
(P) unclassified |
| D01656 |
Brovincamine fumarate (JAN); Sabromin (TN) |
(P) unclassified |
| D01657 |
Lormetazepam (JAN/USAN/INN); Loramet (TN) |
(P) unclassified |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) CYP inhibition: CYP3A4 |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) CYP inhibition: CYP3A4 |
| D01712 |
Theophylline sodium acetate (JAN) |
(P) unclassified |
| D01741 |
Celiprolol hydrochloride (JAN/USAN); Selectol (TN) |
(P) unclassified |
| D01744 |
Brotizolam (JP19/USAN/INN); Lendormin (TN) |
(P) CYP inhibition: CYP3A4 |
| D01745 |
Domperidone (JP19/USAN/INN); Motilium (TN) |
(P) CYP inhibition: CYP3A4 |
| D01758 |
Haloxazolam (JP19/INN); Somelin (TN) |
(P) unclassified |
| D01771 |
Proxyphylline (JAN/INN); Monophyllin (TN) |
(P) unclassified |
| D01785 |
Pirmenol hydrochloride hydrate (JAN) |
(P) unclassified |
| D01787 |
Sulthiame (USAN); Sultiame (JP19); Ospolot (TN) |
(P) unclassified |
| D01793 |
Bifemelane hydrochloride (JAN) |
(P) unclassified |
| D01794 |
Bopindolol malonate (JAN); Sandonorm (TN) |
(P) CYP inhibition: CYP2D6 |
| D01795 |
Tilisolol hydrochloride (JAN); Selecal (TN) |
(P) unclassified |
| D01806 |
Oxprenolol hydrochloride (JP19/USP); Okuspurecol (TN) |
(P) unclassified |
| D01830 |
Arotinolol hydrochloride (JP19); Almarl (TN) |
(P) unclassified |
| D01847 |
Landiolol hydrochloride (JAN/USAN); ONO 1101 hydrochloride; Onoact (TN); Rapiblyk (TN) |
(P) unclassified |
| D01849 |
Lercanidipine hydrochloride (JAN/USAN); Cardiovasc (TN) |
(P) unclassified |
| D01856 |
Nifekalant hydrochloride (JAN); MS 551; Shinbit (TN) |
(P) unclassified |
| D01896 |
Cilostazol (JP19/USP/INN); Pletal (TN) |
(P) CYP inhibition: CYP3A4 |
| D01898 |
Haloperidol decanoate (JAN/USP); Halomonth (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D01908 |
Nilvadipine (JP19/USAN/INN); Nivadil (TN) |
(P) CYP inhibition: CYP3A4 |
| D01933 |
Vatanidipine hydrochloride (JAN); AE 0047; Calbren (TN) |
(P) unclassified |
| D01958 |
Indenolol hydrochloride (JP19) |
(P) unclassified |
| D01969 |
Gallopamil hydrochloride (JAN) |
(P) unclassified |
| D01977 |
Gefitinib (JP19/USAN/INN); Iressa (TN) |
(P) unclassified |
| D02008 |
Tadalafil (JAN/USP/INN); Adcirca (TN); Cialis (TN); Zalutia (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D02009 |
Erythromycin lactobionate (JP19/USP); Erythrocin (TN) |
(P) unclassified |
| D02017 |
Oxtriphylline (USP); Choline theophyllinate (INN); Choline theophylline (JAN); Theophyline and choline; Theocolin (TN) |
(P) unclassified |
| D02045 |
Benidipine hydrochloride (JP19); KW 3049; Coniel (TN) |
(P) CYP inhibition: CYP3A4 |
| D02081 |
Metipranolol hydrochloride; Optipranolol (TN) |
(P) unclassified |
| D02086 |
Lidocaine hydrochloride (JAN/USP); Dalcaine (TN); Xylocaine (TN) |
(P) CYP inhibition: CYP3A4 |
| D02087 |
Moricizine hydrochloride (USP); Ethmozine (TN) |
(P) unclassified |
| D02088 |
Tocainide hydrochloride (USP); Tonocard (TN) |
(P) unclassified |
| D02096 |
Fosphenytoin sodium (USP); Cerebyx (TN); Sesquient (TN) |
(P) unclassified |
| D02097 |
Tiagabine hydrochloride (USP); Gabitril (TN) |
(P) unclassified |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP19); Aleviatin (TN); Dilantin (TN) |
(P) unclassified |
| D02114 |
Hydroxychloroquine sulfate (JAN/USP); Plaquenil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02184 |
Erythromycin stearate (JP19/USP); Bristamycin (TN) |
(P) unclassified |
| D02214 |
Epirubicin hydrochloride (JP19/USP); EPI; Ellence (TN) |
(P) unclassified |
| D02219 |
Terbinafine hydrochloride (JP19/USP); Lamisil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02229 |
Sildenafil citrate (JAN/USP); Revatio (TN); Viagra (TN) |
(P) CYP inhibition: CYP3A4 |
| D02239 |
Sparteine sulfate (JAN/USAN); Sparteine sulfate pentahydrate |
(P) CYP inhibition: CYP2D6 |
| D02260 |
Paroxetine hydrochloride hemihydrate (USP); Paroxetine hydrochloride hydrate (JP19); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D02272 |
Quinidine sulfate (USP); Quinidine sulfate hydrate (JP19); Quinidex (TN) |
(P) CYP inhibition: CYP3A4 |
| D02338 |
Acebutolol (USAN/INN) |
(P) unclassified |
| D02342 |
Bisoprolol (JAN/USAN/INN) |
(P) unclassified |
| D02356 |
Verapamil (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D02358 |
Metoprolol (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D02360 |
Sertraline (INN) |
(P) CYP inhibition: CYP3A4 |
| D02362 |
Paroxetine (USP/INN) |
(P) CYP inhibition: CYP2D6 |
| D02372 |
Perospirone hydrochloride hydrate (JP19); Lullan (TN) |
(P) unclassified |
| D02374 |
Metipranolol (USAN/INN) |
(P) unclassified |
| D02389 |
Primidolol (USAN/INN) |
(P) unclassified |
| D02408 |
Trimipramine maleate (JAN/USP); Surmontil (TN) |
(P) unclassified |
| D02409 |
Caffeine and sodium benzoate (JP19); Sodium caffeine benzoate; Annaca (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02523 |
Erythromycin acistrate (USAN); Erasis (TN) |
(P) unclassified |
| D02524 |
Erythromycin gluceptate (USP); Erythromycin glucoheptonate; Ilotycin gluceptate (TN) |
(P) unclassified |
| D02525 |
Erythromycin propionate (USAN) |
(P) unclassified |
| D02537 |
Dronedarone (INN) |
(P) unclassified |
| D02559 |
Toloxatone (INN); Humoryl (TN) |
(P) unclassified |
| D02561 |
Moclobemide (USAN/INN); Aurorix (TN) |
(P) unclassified |
| D02565 |
Dimetacrine (INN) |
(P) unclassified |
| D02566 |
Maprotiline (USAN) |
(P) CYP inhibition: CYP2D6 |
| D02567 |
Escitalopram oxalate (JAN/USP); Lexapro (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D02570 |
Desvenlafaxine succinate (USAN); Desvenlafaxine succinate hydrate (JAN); Desvenlafaxine succinate monohydrate; Pristiq (TN) |
(P) CYP inhibition: CYP3A4 |
| D02572 |
Viloxazine hydrochloride (USAN); Qelbree (TN); Vivalan (TN) |
(P) CYP inhibition: CYP2D6 |
| D02573 |
Reboxetine mesylate (USAN); Reboxetine mesilate; Vestra (TN) |
(P) unclassified |
| D02574 |
Atomoxetine hydrochloride (JAN/USP); Tomoxetine hydrochloride; Strattera (TN) |
(P) CYP inhibition: CYP2D6 |
| D02575 |
Tianeptine (INN); Stablon (TN) |
(P) unclassified |
| D02578 |
Agomelatine (INN); Valdoxan (TN) |
(P) unclassified |
| D02579 |
Iproniazid (INN) |
(P) unclassified |
| D02580 |
Isocarboxazid (INN); Marplan (TN) |
(P) unclassified |
| D02587 |
Metildigoxin (JP19); Lanirapid (TN) |
(P) unclassified |
| D02600 |
Demoxepam (USAN/INN) |
(P) unclassified |
| D02624 |
Eszopiclone (JAN/USP/INN); Estorra (TN); Lunesta (TN) |
(P) CYP inhibition: CYP3A4 |
| D02629 |
Fluspirilene (USAN/INN); Imap (TN) |
(P) unclassified |
| D02630 |
Penfluridol (USAN/INN); Semap (TN) |
(P) unclassified |
| D02633 |
Lomerizine hydrochloride (JAN); Terranas (TN) |
(P) unclassified |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
| D02704 |
Tampramine fumarate (USAN) |
(P) unclassified |
| D02732 |
Pranlukast hydrate (JP19); Onon (TN) |
(P) CYP inhibition: CYP3A4 |
| D02746 |
Acecainide hydrochloride (USAN) |
(P) unclassified |
| D02765 |
Adaprolol maleate (USAN) |
(P) unclassified |
| D02766 |
Valpromide (INN); Depamide (TN) |
(P) unclassified |
| D02770 |
Adinazolam (USAN/INN) |
(P) unclassified |
| D02771 |
Adinazolam mesylate (USAN) |
(P) unclassified |
| D02787 |
Alaproclate (USAN/INN) |
(P) unclassified |
| D02834 |
Alprenoxime hydrochloride (USAN) |
(P) unclassified |
| D02884 |
Ambuphylline (USAN); Bufylline (BAN); Butaphyllamine (TN) |
(P) unclassified |
| D02910 |
Amiodarone (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D02914 |
Amlodipine maleate (USAN); Amvaz (TN) |
(P) CYP inhibition: CYP3A4 |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) CYP inhibition: CYP3A4 |
| D02969 |
Aprindine (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D02985 |
Arofylline (USAN/INN) |
(P) unclassified |
| D03037 |
Azimilide dihydrochloride (USAN) |
(P) unclassified |
| D03038 |
Azipramine hydrochloride (USAN) |
(P) unclassified |
| D03051 |
Bamifylline hydrochloride (USAN) |
(P) unclassified |
| D03067 |
Belfosdil (USAN/INN) |
(P) unclassified |
| D03083 |
Bentazepam (USAN/INN) |
(P) unclassified |
| D03098 |
Berythromycin (USAN/INN); Erythromycin B |
(P) unclassified |
| D03150 |
Bortezomib (JAN/USAN/INN); Velcade (TN) |
(P) unclassified |
| D03164 |
Bromindione (USAN/INN) |
(P) unclassified |
| D03170 |
Bucindolol hydrochloride (USAN) |
(P) unclassified |
| D03177 |
Bunolol hydrochloride (USAN) |
(P) unclassified |
| D03198 |
Butoxamine hydrochloride (USAN) |
(P) unclassified |
| D03199 |
Butriptyline hydrochloride (USAN) |
(P) unclassified |
| D03218 |
Axitinib (JAN/USAN); Inlyta (TN) |
(P) CYP inhibition: CYP3A4 |
| D03260 |
Vardenafil hydrochloride hydrate (JAN); Vardenafil monohydrochloride trihydrate; Levitra (TN); Staxyn (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D03306 |
Calcium polycarbophil (USP); Polycarbophil calcium (JAN); Mitrolan (TN) |
(P) unclassified |
| D03449 |
Cetamolol hydrochloride (USAN) |
(P) unclassified |
| D03490 |
Cicloprolol hydrochloride (USAN) |
(P) unclassified |
| D03491 |
Cidoxepin hydrochloride (USAN) |
(P) unclassified |
| D03492 |
Cifenline (USAN); Cibenzoline (INN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D03516 |
Cipamfylline (USAN/INN) |
(P) unclassified |
| D03536 |
Clentiazem maleate (JAN/USAN) |
(P) unclassified |
| D03562 |
Clorazepate monopotassium (USAN) |
(P) unclassified |
| D03631 |
Cyprazepam (USAN/INN) |
(P) unclassified |
| D03655 |
Darodipine (USAN/INN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D03729 |
Dexpropranolol hydrochloride (USAN) |
(P) unclassified |
| D03732 |
Dexsotalol hydrochloride (USAN) |
(P) unclassified |
| D03737 |
Dextofisopam (USAN/INN) |
(P) unclassified |
| D03759 |
Diacetolol hydrochloride (USAN) |
(P) unclassified |
| D03798 |
Dicumarol (USAN); Dicoumarol (INN) |
(P) unclassified |
| D03799 |
Dienogest (JAN/USAN/INN); Endometrion (TN) |
(P) CYP inhibition: CYP3A4 |
| D03820 |
Dutasteride (JAN/USP/INN); Avodart (TN) |
(P) CYP inhibition: CYP3A4 |
| D03830 |
Diltiazem malate (USAN); Tiamate (TN) |
(P) CYP inhibition: CYP3A4 |
| D03844 |
Phenytoin, phenobarbital and caffeine and sodium benzoate; Hydantol F (TN) |
(P) unclassified |
| D03898 |
Doxofylline (USAN/INN); Maxivent (TN) |
(P) unclassified |
| D03914 |
Dronedarone hydrochloride (USP); Multaq (TN) |
(P) unclassified |
| D03991 |
Encainide hydrochloride (USAN) |
(P) CYP inhibition: CYP2D6 |
| D04006 |
Enprofylline (USAN/INN) |
(P) unclassified |
| D04023 |
Erlotinib hydrochloride (JAN/USAN); Tarceva (TN) |
(P) CYP inhibition: CYP3A4 |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) CYP inhibition: CYP3A4 |
| D04054 |
Erythromycin salnacedin (USAN); Erythromycin salnacedin dihydrate |
(P) unclassified |
| D04105 |
Etoperidone hydrochloride (USAN); Etonin (TN) |
(P) unclassified |
| D04147 |
Fenethylline hydrochloride (USAN) |
(P) unclassified |
| D04148 |
Fenfluramine hydrochloride (JAN/USAN); Fintepla (TN); Pondimin (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D04190 |
Flestolol sulfate (USAN) |
(P) unclassified |
| D04193 |
Flordipine (USAN/INN) |
(P) unclassified |
| D04248 |
Fosazepam (USAN/INN) |
(P) unclassified |
| D04260 |
Fostedil (USAN/INN) |
(P) unclassified |
| D04300 |
Ganaxolone (USAN/INN); Ztalmy (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D04314 |
Gepirone hydrochloride (USAN); Exxua (TN) |
(P) CYP inhibition: CYP3A4 |
| D04340 |
Dextromethorphan hydrobromide and potassium cresolsulfonate; Medicon (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D04556 |
Intriptyline hydrochloride (USAN) |
(P) unclassified |
| D04605 |
Iprindole (USAN/INN) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) CYP inhibition: CYP3A4 |
| D04650 |
Ketazolam (USAN/INN) |
(P) unclassified |
| D04652 |
Ketipramine fumarate (USAN) |
(P) unclassified |
| D04657 |
Lacidipine (USAN/INN); Motens (TN) |
(P) unclassified |
| D04710 |
Levobetaxolol hydrochloride (USAN); Betaxon (TN) |
(P) unclassified |
| D04721 |
Levotofisopam (USAN/INN) |
(P) unclassified |
| D04733 |
Lidoflazine (USAN/INN); Angex (TN) |
(P) unclassified |
| D04748 |
Lisofylline (USAN/INN); ProTec (TN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(CI,P) unclassified |
| D04774 |
Lorajmine hydrochloride (USAN) |
(P) unclassified |
| D04778 |
Lorcainide hydrochloride (USAN) |
(P) unclassified |
| D04820 |
Lurasidone hydrochloride (JAN/USAN); SM 13496; Latuda (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D04882 |
Medazepam hydrochloride (USAN); Nobrium (TN) |
(P) unclassified |
| D04888 |
Medroxalol (USAN/INN) |
(P) unclassified |
| D04889 |
Medroxalol hydrochloride (USAN) |
(P) unclassified |
| D04905 |
Memantine hydrochloride (JAN/USP); Namenda (TN); Memary (TN) |
(P) unclassified |
| D04955 |
Sematilide hydrochloride (USAN) |
(P) unclassified |
| D05011 |
Metoprolol fumarate (USP); Lopressor (TN) |
(P) CYP inhibition: CYP2D6 |
| D05024 |
Mibefradil dihydrochloride (USAN); Posicor (TN) |
(P) unclassified |
| D05028 |
Midazolam maleate (USAN) |
(P) CYP inhibition: CYP3A4 |
| D05039 |
Minaprine (USAN/INN); Cantor (TN) |
(P) CYP inhibition: CYP2D6 |
| D05040 |
Minaprine hydrochloride (USAN) |
(P) CYP inhibition: CYP2D6 |
| D05077 |
Moricizine (USAN); Moracizine (INN) |
(P) unclassified |
| D05125 |
Naxifylline (USAN/INN) |
(P) unclassified |
| D05127 |
Nebivolol (USAN/INN) |
(P) CYP inhibition: CYP2D6 |
| D05200 |
Nomifensine maleate (USAN); Merital (TN) |
(P) unclassified |
| D05231 |
Octriptyline phosphate (USAN) |
(P) unclassified |
| D05345 |
Pamatolol sulfate (USAN) |
(P) unclassified |
| D05374 |
Paroxetine hydrochloride (USP); Paxil (TN) |
(P) CYP inhibition: CYP2D6 |
| D05375 |
Paroxetine mesylate (USAN); Brisdelle (TN); Pexeva (TN) |
(P) CYP inhibition: CYP2D6 |
| D05380 |
Pazopanib hydrochloride (JAN/USAN); Votrient (TN) |
(P) unclassified |
| D05429 |
Aminophylline hydrate (JP19) |
(P) unclassified |
| D05442 |
Perhexiline maleate (USAN) |
(P) CYP inhibition: CYP2D6 |
| D05457 |
Phenprocoumon (USAN/INN); Liquamar (TN) |
(P) unclassified |
| D05462 |
Oxycodone hydrochloride hydrate (JP19) |
(P) CYP inhibition: CYP3A4 |
| D05587 |
Practolol (USAN) |
(P) unclassified |
| D05621 |
Progabide (USAN/INN); Gabren (TN) |
(P) unclassified |
| D05710 |
Reclazepam (USAN/INN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) CYP inhibition: CYP3A4 |
| D05942 |
Sulazepam (USAN/INN) |
(P) unclassified |
| D06012 |
Tazifylline hydrochloride (USAN) |
(P) unclassified |
| D06060 |
Teludipine hydrochloride (USAN) |
(P) unclassified |
| D06068 |
Temsirolimus (JAN/USAN/INN); Torisel (TN) |
(P) CYP inhibition: CYP3A4 |
| D06103 |
Theophylline (USP); Theophylline monohydrate; Accurbron (TN) |
(P) unclassified |
| D06104 |
Theophylline sodium glycinate (USP); Asbron (TN) |
(P) unclassified |
| D06129 |
Tiapamil hydrochloride (USAN) |
(P) unclassified |
| D06162 |
Tiprenolol hydrochloride (USAN) |
(P) unclassified |
| D06172 |
Tocainide (USAN/INN) |
(P) unclassified |
| D06176 |
Tolamolol (USAN/INN) |
(P) unclassified |
| D06199 |
Trabectedin (JAN/USAN/INN); Yondelis (TN) |
(P) CYP inhibition: CYP3A4 |
| D06231 |
Triflubazam (USAN/INN) |
(P) unclassified |
| D06273 |
Imidafenacin (JAN/INN); Uritos (TN); Staybla (TN) |
(P) CYP inhibition: CYP3A4 |
| D06282 |
Varenicline tartrate (JAN/USAN); Chantix (TN); Champix (TN); Tyrvaya (TN) |
(P) unclassified |
| D06291 |
Verofylline (USAN/INN) |
(P) unclassified |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) CYP inhibition: CYP3A4 |
| D06334 |
Xanthinol niacinate (USAN); Xantinol nicotinate; Complamin (TN) |
(P) unclassified |
| D06363 |
Ziconotide (USAN/INN); Prialt (TN) |
(P) unclassified |
| D06367 |
Zimeldine hydrochloride (USAN); Zimeldine hydrochloride hydrate |
(P) unclassified |
| D06402 |
Sunitinib malate (JAN/USAN); Sutent (TN) |
(P) CYP inhibition: CYP3A4 |
| D06405 |
Nalfurafine hydrochloride (JAN/USAN); Remitch (TN) |
(P) CYP inhibition: CYP3A4 |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) CYP inhibition: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) CYP inhibition: CYP3A4 |
| D06517 |
Pirmenol hydrochloride (USAN); Pirmavar (TN) |
(P) unclassified |
| D06573 |
Carisbamate (USAN) |
(P) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) CYP inhibition: CYP3A4 |
| D06622 |
Nebivolol hydrochloride (USAN); Bystolic (TN) |
(P) CYP inhibition: CYP2D6 |
| D06637 |
Romidepsin (JAN/USAN/INN); Istodax (TN) |
(P) unclassified |
| D06646 |
Epanolol (USAN/INN) |
(P) unclassified |
| D06652 |
Tedisamil (USAN) |
(P) unclassified |
| D06653 |
Tedisamil sesquifumarate (USAN) |
(P) unclassified |
| D06665 |
Vernakalant hydrochloride (USAN) |
(P) unclassified |
| D07062 |
Acefylline piperazine (INN); Epicophylline (TN) |
(P) unclassified |
| D07064 |
Acenocoumarol (INN); Acenocoumarin; Mini-sintrom (TN) |
(P) unclassified |
| D07131 |
Ethyl biscoumacetate (INN) |
(P) unclassified |
| D07135 |
Clorindione (INN); G-25766 |
(P) unclassified |
| D07136 |
Diphenadione (INN) |
(P) unclassified |
| D07137 |
Tioclomarol (INN) |
(P) unclassified |
| D07139 |
Cloricromen (INN) |
(P) unclassified |
| D07151 |
Cafedrine (BAN) |
(P) unclassified |
| D07155 |
Theodrenaline (INN) |
(P) unclassified |
| D07156 |
Alprenolol (INN) |
(P) CYP inhibition: CYP2D6 |
| D07174 |
Pentifylline (INN) |
(P) unclassified |
| D07181 |
Mepindolol (INN) |
(P) unclassified |
| D07182 |
Tertatolol (INN) |
(P) unclassified |
| D07183 |
Cloranolol (INN) |
(P) unclassified |
| D07184 |
Talinolol (INN) |
(P) unclassified |
| D07185 |
Fendiline (INN) |
(P) unclassified |
| D07283 |
Esketamine (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D07298 |
Barbexaclone (INN); Maliasin (TN) |
(P) unclassified |
| D07299 |
Lacosamide (JAN/USAN/INN); Erlosamide; Vimpat (TN) |
(P) CYP inhibition: CYP3A4 |
| D07300 |
Beclamide (INN) |
(P) unclassified |
| D07314 |
Pinazepam (INN); Domar (TN) |
(P) unclassified |
| D07315 |
Camazepam (INN) |
(P) unclassified |
| D07326 |
Loprazolam (INN); Dormonoct (TN) |
(P) unclassified |
| D07327 |
Doxefazepam (INN) |
(P) unclassified |
| D07328 |
Cinolazepam (INN); Gerodorm (TN) |
(P) unclassified |
| D07334 |
Imipraminoxide (INN) |
(P) unclassified |
| D07335 |
Amineptine (INN); Survector (TN) |
(P) unclassified |
| D07336 |
Quinupramine (INN) |
(P) unclassified |
| D07337 |
Nialamide (INN); Niamid (TN) |
(P) unclassified |
| D07338 |
Iproclozide (INN) |
(P) unclassified |
| D07339 |
Oxitriptan (INN); Levothym (TN) |
(P) unclassified |
| D07340 |
Oxaflozane (INN) |
(P) unclassified |
| D07341 |
Medifoxamine (INN) |
(P) unclassified |
| D07342 |
Pivagabine (INN) |
(P) unclassified |
| D07378 |
Etamiphylline (INN) |
(P) unclassified |
| D07428 |
Bunaftine (INN) |
(P) unclassified |
| D07448 |
Amitriptyline (INN); Laroxyl (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07450 |
Amlodipine (USP/INN); Norvasc (TN) |
(P) CYP inhibition: CYP3A4 |
| D07457 |
Anisindione (INN); Miradon (TN) |
(P) unclassified |
| D07465 |
Arotinolol (INN) |
(P) unclassified |
| D07491 |
Bamifylline (INN) |
(P) unclassified |
| D07494 |
Barnidipine (INN); Vasexten (TN) |
(P) CYP inhibition: CYP3A4 |
| D07496 |
Befunolol (INN) |
(P) unclassified |
| D07505 |
Latanoprost and timolol maleate; Xalacom (TN) |
(P) unclassified |
| D07509 |
Benidipine (INN) |
(P) CYP inhibition: CYP3A4 |
| D07520 |
Bepridil (INN); Bepadin (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07526 |
Betaxolol (INN) |
(P) unclassified |
| D07528 |
Bifemelane (INN) |
(P) unclassified |
| D07537 |
Bopindolol (INN); Sandonorm (TN) |
(P) CYP inhibition: CYP2D6 |
| D07545 |
Brovincamine (INN); Sarbromin (TN) |
(P) unclassified |
| D07569 |
Candesartan cilexetil and anmlodipine besylate (JP19); Unisia (TN) |
(P) CYP inhibition: CYP3A4 |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) unclassified |
| D07590 |
Bupranolol (INN) |
(P) unclassified |
| D07591 |
Bupropion (INN) |
(P) unclassified |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) unclassified |
| D07601 |
Butriptyline (INN); Evadyne (TN) |
(P) unclassified |
| D07603 |
Caffeine citrate (USP); Cafcit (TN) |
(P) unclassified |
| D07608 |
Carazolol (INN); Conducton (TN); Suacron [veterinary] (TN) |
(P) unclassified |
| D07624 |
Carteolol (INN) |
(P) CYP inhibition: CYP2D6 |
| D07660 |
Celiprolol (INN) |
(P) unclassified |
| D07704 |
Citalopram (USP/INN); Citadur (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07705 |
Citalopram hydrochloride; Seropram (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07714 |
Climazolam (INN); Climasol [veterinary] (TN) |
(P) unclassified |
| D07727 |
Clomipramine (INN); Anafranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07736 |
Cloricromen hydrohloride; Proendotel (TN) |
(P) unclassified |
| D07784 |
Delorazepam (INN); Dadumir (TN) |
(P) unclassified |
| D07791 |
Desipramine (INN) |
(P) unclassified |
| D07793 |
Desvenlafaxine (INN); Khedezla (TN) |
(P) CYP inhibition: CYP3A4 |
| D07812 |
Dibenzepin (INN) |
(P) unclassified |
| D07845 |
Diltiazem (INN); Surazem (TN) |
(P) CYP inhibition: CYP3A4 |
| D07862 |
Diphenylpyraline (INN) |
(P) unclassified |
| D07869 |
Donepezil (JAN/INN); Donaz (TN); Allydone (TN) |
(P) CYP inhibition: CYP3A4 |
| D07872 |
Dosulepin (INN); Dothiepin; Dothep (TN) |
(P) CYP inhibition: CYP2D6 |
| D07875 |
Doxepin (INN); Sinequan (TN) |
(P) CYP inhibition: CYP2D6 |
| D07880 |
Duloxetine (INN); Yentreve (TN) |
(P) unclassified |
| D07886 |
Efonidipine (INN) |
(P) unclassified |
| D07894 |
Encainide (INN) |
(P) CYP inhibition: CYP2D6 |
| D07909 |
Erythromycin thiocyanate; Erythrocin (TN) |
(P) unclassified |
| D07910 |
Erythromycin stinoprate (INN); Erysec (TN) |
(P) unclassified |
| D07913 |
Escitalopram (INN); Esertia (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07916 |
Esmolol (INN) |
(P) unclassified |
| D07923 |
Etamiphylline hydrochloride; Solufilina (TN) |
(P) unclassified |
| D07933 |
Etofylline (INN); Oxyphyllin (TN) |
(P) unclassified |
| D07938 |
Bupropion hydrobromide (USAN); Aplenzin (TN) |
(P) unclassified |
| D07943 |
Fendiline hydrochloride; Sensit (TN) |
(P) unclassified |
| D07944 |
Fenetylline (INN); Fenethylline; Fitton (TN) |
(P) unclassified |
| D07945 |
Fenfluramine (INN); Ponderax (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D07962 |
Flecainide (INN) |
(P) CYP inhibition: CYP2D6 |
| D07969 |
Fluindione (INN); Previsccan (TN) |
(P) unclassified |
| D07971 |
Flunarizine (INN); Sibelium (TN) |
(P) CYP inhibition: CYP2D6 |
| D07984 |
Fluvoxamine (INN) |
(P) CYP inhibition: CYP2D6 |
| D07993 |
Fosphenytoin (INN) |
(P) unclassified |
| D08009 |
Gallopamil (INN) |
(P) unclassified |
| D08020 |
Lorcainide (INN) |
(P) unclassified |
| D08048 |
Hydroquinidine (DCF); Dihydroquinidine |
(P) unclassified |
| D08049 |
Hydroquinidine hydrochloride; Idrochinidine (TN); Serecor (TN) |
(P) unclassified |
| D08060 |
Ibutilide (INN) |
(P) unclassified |
| D08070 |
Imipramine (INN); Tofranil (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08071 |
Imipramine pamoate (USP); Imipramine embonate; Tofranil-pm (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08072 |
Imipraminoxide hydrochloride; Elepsin (TN) |
(P) unclassified |
| D08074 |
Penbutolol (INN) |
(P) unclassified |
| D08078 |
Indenolol (INN) |
(P) unclassified |
| D08085 |
Iproniazid phosphate; Marsilid (TN) |
(P) unclassified |
| D08095 |
Ivabradine hydrochloride (JAN/USAN); Ivabrandine hydrochloride; Corlanor (TN); Corlentor (TN); Coralan (TN) |
(P) CYP inhibition: CYP3A4 |
| D08106 |
Labetalol (INN) |
(P) unclassified |
| D08111 |
Lercanidipine (INN); Lercanil (TN) |
(P) unclassified |
| D08115 |
Levobunolol (INN) |
(P) unclassified |
| D08127 |
Lidocaine hydrochloride monohydrate; Lidocaine (TN); Zingo (TN) |
(P) CYP inhibition: CYP3A4 |
| D08140 |
Lofepramine (INN) |
(P) unclassified |
| D08145 |
Loprazolam mesilate; Loprazolam mesylate; Loprazolam methanesulfonate; Havlane (TN) |
(P) unclassified |
| D08155 |
Manidipine (INN); Manidipine 6300; Artedil (TN) |
(P) CYP inhibition: CYP3A4 |
| D08171 |
Melitracen (INN); Adelax (TN) |
(P) unclassified |
| D08215 |
Mexiletine (INN) |
(P) CYP inhibition: CYP2D6 |
| D08216 |
Mianserin (INN); Tolvon (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08217 |
Mibefradil (INN) |
(P) unclassified |
| D08222 |
Milnacipran (INN) |
(P) unclassified |
| D08257 |
Nefazodone (INN) |
(P) unclassified |
| D08270 |
Nicardipine (INN); Cardene (TN) |
(P) CYP inhibition: CYP3A4 |
| D08283 |
Nordazepam (INN); Calmday (TN) |
(P) CYP inhibition: CYP3A4 |
| D08288 |
Nortriptyline (INN); Nortrilen (TN) |
(P) CYP inhibition: CYP2D6 |
| D08297 |
Opipramol (INN) |
(P) unclassified |
| D08318 |
Oxprenolol (INN) |
(P) unclassified |
| D08340 |
Perhexiline (INN) |
(P) CYP inhibition: CYP2D6 |
| D08349 |
Phenelzine (BAN) |
(P) unclassified |
| D08354 |
Phenindione (INN); Hedulin (TN) |
(P) unclassified |
| D08356 |
Phenobarbital diethylamine; Gratusminal (TN) |
(P) unclassified |
| D08377 |
Pilsicainide (INN) |
(P) unclassified |
| D08394 |
Pirmenol (INN) |
(P) unclassified |
| D08421 |
Procainamide (INN) |
(P) unclassified |
| D08435 |
Propafenone (INN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08443 |
Propranolol (INN) |
(P) CYP inhibition: CYP2D6 |
| D08447 |
Protriptyline (INN) |
(P) unclassified |
| D08458 |
Quinidine (BAN) |
(P) CYP inhibition: CYP3A4 |
| D08459 |
Quinidine phenylethylbarbiturate; Quinidine 5-ethyl 5-phenyl barbiturate; Natisedine (TN) |
(P) CYP inhibition: CYP3A4 |
| D08472 |
Reboxetine (INN); Edronax (TN) |
(P) unclassified |
| D08481 |
Rilmazafone (INN) |
(P) CYP inhibition: CYP3A4 |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) CYP inhibition: CYP3A4 |
| D08493 |
Dorzolamide hydrochloride and timolol maleate (JP19); Cosopt (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08497 |
Rupatadine fumarate (JAN/USAN); Rinialer (TN); Rupafin (TN) |
(P) CYP inhibition: CYP3A4 |
| D08525 |
Sotalol (INN); Darob mite (TN) |
(P) unclassified |
| D08572 |
Tertatolol hydrochloride; Artex (TN) |
(P) unclassified |
| D08575 |
Tetrabenazine (JAN/INN); Nitoman (TN); Xenazine (TN) |
(P) CYP inhibition: CYP2D6 |
| D08588 |
Tiagabine (INN); Gabitril (TN) |
(P) unclassified |
| D08589 |
Tianeptine sodium; Stablon (TN) |
(P) unclassified |
| D08598 |
Tilisolol (INN) |
(P) unclassified |
| D08600 |
Timolol (INN); Betimol (TN) |
(P) CYP inhibition: CYP2D6 |
| D08625 |
Tranylcypromine (INN); Parnate (TN) |
(P) unclassified |
| D08626 |
Trazodone (INN); Trittico (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08667 |
Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
(P) unclassified |
| D08670 |
Venlafaxine (INN); Efectin (TN) |
(P) CYP inhibition: CYP2D6 |
| D08673 |
Viloxazine (INN) |
(P) CYP inhibition: CYP2D6 |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) unclassified |
| D08686 |
Ziconotide acetate; Prialt (TN) |
(P) unclassified |
| D08699 |
Salmeterol xinafoate and fluticasone propionate; Adoair diskus (TN); Aerivio Spiromax (TN) |
(P) CYP inhibition: CYP3A4 |
| D08856 |
Anamorelin hydrochloride (JAN/USAN); Adlumiz (TN) |
(P) CYP inhibition: CYP3A4 |
| D08879 |
Brivaracetam (JAN/USAN/INN); Briviact (TN) |
(P) unclassified |
| D08892 |
Clevidipine (USAN/INN); Clevidipine butyrate; Cleviprex (TN) |
(P) unclassified |
| D08923 |
Fesoterodine fumarate (JAN/USAN); Toviaz (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D08962 |
Pamabrom (USP) |
(P) unclassified |
| D08964 |
Perampanel (JAN/USAN); Fycompa (TN) |
(P) unclassified |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) CYP inhibition: CYP3A4 |
| D08989 |
Rolofylline (USAN) |
(P) unclassified |
| D09017 |
Ticagrelor (JAN/USAN/INN); Brilinta (TN) |
(CI,P) unclassified |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D09215 |
Eslicarbazepine (USAN/INN) |
(P) unclassified |
| D09319 |
Indacaterol maleate (JAN/USAN); Arcapta (TN) |
(P) CYP inhibition: CYP3A4 |
| D09348 |
Fostamatinib disodium (USAN); Fostamatinib sodium hydrate (JAN); Fostamatinib disodium hexahydrate; Tavalisse (TN) |
(P) CYP inhibition: CYP3A4 |
| D09365 |
Palovarotene (JAN/USAN/INN); Sohonos (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D09569 |
Ezogabine (USAN); Retigabine (INN); Potiga (TN) |
(P) unclassified |
| D09572 |
Riociguat (JAN/USAN/INN); Adempas (TN) |
(P) unclassified |
| D09587 |
Brentuximab vedotin (USAN/INN); Brentuximab vedotin (genetical recombination) (JAN); Adcetris (TN) |
(P) unclassified |
| D09594 |
Olmesartan medoxomil and azelnidipine; Rezaltas (TN) |
(P) CYP inhibition: CYP3A4 |
| D09595 |
Budesonide and formoterol fumarate dihydrate; Symbicort (TN); Budeforu (TN) |
(P) CYP inhibition: CYP3A4 |
| D09612 |
Eslicarbazepine acetate (USAN); Zebinix (TN); Aptiom (TN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(CI,P) CYP inhibition: CYP3A4 |
| D09676 |
Tecarfarin (USAN/INN) |
(P) unclassified |
| D09677 |
Tecarfarin sodium (USAN) |
(P) unclassified |
| D09684 |
Tonapofylline (USAN/INN) |
(P) unclassified |
| D09698 |
Vilazodone (USAN/INN) |
(P) CYP inhibition: CYP3A4 |
| D09699 |
Vilazodone hydrochloride (USAN); Viibryd (TN) |
(P) CYP inhibition: CYP3A4 |
| D09728 |
Bosutinib hydrate (JAN); Bosutinib monohydrate; Bosulif (TN) |
(P) CYP inhibition: CYP3A4 |
| D09730 |
Olaparib (JAN/USAN/INN); Lynparza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) CYP inhibition: CYP3A4 |
| D09743 |
Telmisartan and amlodipine besilate (JP19); Telmisartan and amlodipine besylate; Micamlo (TN); Twynsta (TN) |
(P) CYP inhibition: CYP3A4 |
| D09744 |
Pioglitazone hydrochloride and metformin hydrochloride (JP19); Pioglitazone and metformin; Metact (TN) |
(P) unclassified |
| D09745 |
Valsartan and amlodipine besilate; Exforge (TN) |
(P) CYP inhibition: CYP3A4 |
| D09753 |
Saxagliptin hydrate (JAN); Onglyza (TN) |
(P) CYP inhibition: CYP3A4 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) CYP inhibition: CYP3A4 |
| D09789 |
Kirenidipine hydrochloride (JAN) |
(P) unclassified |
| D09807 |
Difethiarol (JAN); Difethialone |
(P) unclassified |
| D09815 |
Travoprost and timolol maleate; Duotrav (TN) |
(P) unclassified |
| D09843 |
Beradilol monoethyl maleate (JAN); TZC-5665 |
(P) unclassified |
| D09847 |
Metildigoxin (INN); Medigoxin (BAN) |
(P) unclassified |
| D09894 |
Eliglustat tartrate (JAN/USAN); Eliglustat hemitartrate; Cerdelga (TN) |
(CI,P) CYP inhibition: CYP2D6 |
| D09951 |
Ponatinib hydrochloride (JAN/USAN); Iclusig (TN) |
(P) unclassified |
| D09956 |
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN); Vanflyta (TN) |
(P) unclassified |
| D09958 |
Rilpivirine hydrochloride (JAN/USAN); Edurant (TN) |
(P) unclassified |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) CYP inhibition: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) unclassified |
| D10024 |
Selumetinib sulfate (JAN/USAN); Koselugo (TN) |
(P) CYP inhibition: CYP3A4 |
| D10072 |
Levomilnacipran (USAN/INN) |
(P) unclassified |
| D10082 |
Suvorexant (JAN/USAN); MK-4305; Belsomra (TN) |
(P) unclassified |
| D10095 |
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN); Cometriq (TN); Cabometyx (TN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) CYP inhibition: CYP3A4 |
| D10133 |
Levomilnacipran hydrochloride (USAN); Fetzima (TN) |
(P) unclassified |
| D10135 |
Macitentan (JAN/USAN); Opsumit (TN) |
(P) CYP inhibition: CYP3A4 |
| D10137 |
Regorafenib hydrate (JAN); Stivarga (TN) |
(P) CYP inhibition: CYP3A4 |
| D10184 |
Vortioxetine (USAN); Brintellix (TN) |
(P) CYP inhibition: CYP2D6 |
| D10185 |
Vortioxetine hydrobromide (JAN/USAN); Brintellix (TN); Trintellix (TN) |
(P) CYP inhibition: CYP2D6 |
| D10223 |
Ibrutinib (JAN/USAN); Imbruvica (TN) |
(P) unclassified |
| D10243 |
Irbesartan and amlodipine besilate (JP19); Aimix (TN) |
(P) CYP inhibition: CYP3A4 |
| D10253 |
Alogliptin benzoate and metformin hydrochloride; Kazano (TN); Vipdomet (TN) |
(P) unclassified |
| D10298 |
Brimonidine tartrate and timolol maleate; Combigan (TN); Aibeta (TN) |
(P) unclassified |
| D10307 |
Avatrombopag maleate (JAN/USAN); Doptelet (TN) |
(P) CYP inhibition: CYP3A4 |
| D10309 |
Brexpiprazole (JAN/USAN/INN); Rexulti (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10450 |
Alectinib hydrochloride (JAN); Alecensa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10452 |
Cabazitaxel acetonate (JAN); Cabazitaxel acetone; Jevtana (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10478 |
Naldemedine tosylate (JAN/USAN); Naldemedine tosilate; Symproic (TN) |
(P) CYP inhibition: CYP3A4 |
| D10501 |
Fluticasone furoate and vilanterol trifenatate; Breo ellipta (TN); Relvar ellipita (TN) |
(P) CYP inhibition: CYP3A4 |
| D10503 |
Ethacizine |
(P) unclassified |
| D10505 |
Glycopyrronium bromide and indacaterol maleate; Ultibro (TN) |
(P) CYP inhibition: CYP3A4 |
| D10506 |
Fluticasone propionate and formoterol fumarate hydrate; Flutiform (TN) |
(P) CYP inhibition: CYP3A4 |
| D10512 |
Brinzolamide and timolol maleate; Azorga (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10516 |
Aripiprazole hydrate (JAN); Aripiprazole monohydrate; Abilify maintena (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10518 |
Valaciclovir hydrochloride hydrate (JAN); Valacyclovir hydrochloride hydrate; Valaciclovir (TN) |
(P) unclassified |
| D10524 |
Azilsartan and amlodipine besilate; Zacras (TN) |
(P) CYP inhibition: CYP3A4 |
| D10525 |
Valsartan and cilnidipine; Atedio (TN) |
(P) CYP inhibition: CYP3A4 |
| D10533 |
Umeclidinium bromide and vilanterol; Anoro (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10569 |
Tafluprost and timolol maleate; Tapcom (TN) |
(P) unclassified |
| D10578 |
Ledipasvir and sofosbuvir; Harvoni (TN) |
(P) unclassified |
| D10627 |
Esketamine hydrochloride (JAN/USAN); Spravato (TN) |
(P) CYP inhibition: CYP3A4 |
| D10633 |
Finerenone (JAN/USAN/INN); Kerendia (TN) |
(P) CYP inhibition: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10663 |
Rimegepant sulfate (USAN); Rimegepant sulfate hydrate (JAN); Nurtec odt (TN); Vydura (TN) |
(P) CYP inhibition: CYP3A4 |
| D10679 |
Venetoclax (JAN/USAN/INN); Venclexta (TN) |
(CI,P) unclassified |
| D10688 |
Abemaciclib (JAN/USAN/INN); Verzenio (TN) |
(P) unclassified |
| D10743 |
Vildagliptin and metformin hydrochloride |
(P) unclassified |
| D10761 |
Polatuzumab vedotin (USAN); Polatuzumab vedotin (genetical recombination) (JAN); Polatuzumab vedotin-piiq; Polivy (TN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D10780 |
Perampanel hydrate (JAN); Fycompa (TN) |
(P) unclassified |
| D10790 |
Mirogabalin besylate (USAN); Mirogabalin besilate (JAN) |
(P) unclassified |
| D10800 |
Gilteritinib fumarate (JAN/USAN); Xospata (TN) |
(P) CYP inhibition: CYP3A4 |
| D10805 |
Telmisartan, amlodipine and hydrochlorothiazide; Micatrio (TN) |
(P) CYP inhibition: CYP3A4 |
| D10827 |
Sofosbuvir and velpatasvir; Epclusa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10836 |
Emtricitabine, rilpivirine and tenofovir alafenamide; Odefsey (TN) |
(P) unclassified |
| D10866 |
Brigatinib (JAN/USAN); Alunbrig (TN) |
(P) CYP inhibition: CYP3A4 |
| D10891 |
Capmatinib hydrochloride (USAN); Capmatinib hydrochloride hydrate (JAN); Tabrecta (TN) |
(P) CYP inhibition: CYP3A4 |
| D10892 |
Esaxerenone (JAN/INN) |
(P) unclassified |
| D10893 |
Acalabrutinib (JAN/USAN/INN); Calquence (TN) |
(P) unclassified |
| D10915 |
Cannabidiol (JAN/USAN/INN); CBD; Epidiolex (TN) |
(P) CYP inhibition: CYP3A4 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) CYP inhibition: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) CYP inhibition: CYP3A4 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) CYP inhibition: CYP3A4 |
| D10932 |
Etripamil (USAN/INN); Cardamyst (TN) |
(P) CYP inhibition: CYP3A4 |
| D10993 |
Tucidinostat (JAN/USAN/INN); Hiyasta (TN) |
(P) unclassified |
| D10999 |
Valbenazine tosylate (USAN); Valbenazine tosilate (JAN); Valbenazine ditosylate; Ingrezza (TN); Dysval (TN) |
(P) CYP inhibition: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11022 |
Lemborexant (JAN/USAN/INN); Dayvigo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11035 |
Fluticasone furoate, umeclidinium bromide and vilanterol; Trelegy ellipta (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) CYP inhibition: CYP3A4 |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) CYP inhibition: CYP3A4 |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) CYP inhibition: CYP3A4 |
| D11056 |
Mirtazapine hydrate (JAN) |
(P) CYP inhibition: CYP2D6 CYP3A4 |
| D11070 |
Tirabrutinib hydrochloride (JAN/USAN); Velexbru (TN) |
(P) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) CYP inhibition: CYP3A4 |
| D11109 |
Anagliptin and Metformin hydrochloride |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11149 |
Brexanolone (USAN/INN); Zulresso (TN) |
(P) unclassified |
| D11150 |
Cenobamate (JAN/USAN/INN); Xcopri (TN) |
(P) CYP inhibition: CYP3A4 |
| D11159 |
Leniolisib phosphate (JAN/USAN); Joenja (TN) |
(P) CYP inhibition: CYP3A4 |
| D11282 |
Dolutegravir sodium and rilpivirine hydrochloride; Juluca (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) CYP inhibition: CYP3A4 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) unclassified |
| D11417 |
Pemigatinib (JAN/USAN/INN); Pemazyre (TN) |
(P) CYP inhibition: CYP3A4 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) CYP inhibition: CYP3A4 |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11525 |
Enfortumab vedotin (USAN); Enfortumab vedotin (genetical recombination) (JAN); Enfortumab vedotin-ejfv; Padcev (TN) |
(P) unclassified |
| D11584 |
Budesonide, glycopyrronium bromide and formoterol fumarate; Budesonide, glycopyrrolate and formoterol fumarate; Breztri (TN) |
(P) unclassified |
| D11619 |
Desvenlafaxine succinate anhydrous |
(P) unclassified |
| D11630 |
Aminophylline dihydrate |
(P) unclassified |
| D11659 |
Tolvaptan sodium phosphate (JAN); Samtasu (TN) |
(P) unclassified |
| D11662 |
Valemetostat tosilate (JAN); Valemetostat tosylate; Ezharmia (TN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11725 |
Futibatinib (JAN/USAN/INN); Lytgobi (TN) |
(P) unclassified |
| D11793 |
Zuranolone (JAN/USAN/INN); Zurzuvae (TN) |
(P) CYP inhibition: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11814 |
Tisotumab vedotin (USAN/INN); Tisotumab vedotin (genetical recombination) (JAN); Tisotumab vedotin-tftv; Tivdak (TN) |
(P) unclassified |
| D11861 |
Indacaterol acetate, glycopyrronium bromide and mometasone furoate; Enerzair (TN) |
(P) unclassified |
| D11862 |
Indacaterol and mometasone furoate; Atectura (TN) |
(P) unclassified |
| D11881 |
Amlodipine benzoate; Katerzia (TN) |
(P) CYP inhibition: CYP3A4 |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D12015 |
St. John's wort; SJW |
(P) unclassified |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12217 |
Imlunestrant tosylate (USAN); Imlunestrant tosilate (JAN); Inluriyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) CYP inhibition: CYP3A4 |
| D12265 |
Mavacamten (JAN/USAN/INN); Camzyos (TN) |
(P) unclassified |
| D12311 |
Bortezomib hydrate (JAN) |
(P) unclassified |
| D12364 |
Taletrectinib adipate (JAN/USAN); Ibtrozi (TN) |
(P) unclassified |
| D12396 |
Sebetralstat (JAN/USAN/INN); Ekterly (TN) |
(P) CYP inhibition: CYP3A4 |
| D12403 |
Venlafaxine besylate monohydrate; Venlafaxine besylate (TN) |
(P) CYP inhibition: CYP2D6 |
| D12410 |
Landiolol (USAN/INN) |
(P) unclassified |
| D12442 |
Tucatinib ethanolate (JAN); Tucatinib hemiethanolate; Tukysa (TN) |
(P) unclassified |
| D12444 |
Nilotinib hydrochloride dihydrate (JAN) |
(P) CYP inhibition: CYP3A4 |
| D12493 |
Dextromethorphan hydrobromide and bupropion hydrochloride; Auvelity (TN) |
(P) CYP inhibition: CYP2D6 |
| D12544 |
Vortioxetine hemihydrobromide (USAN) |
(P) CYP inhibition: CYP2D6 |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12611 |
Vornorexant hydrate (JAN) |
(P) CYP inhibition: CYP3A4 |
| D12704 |
Acalabrutinib maleate hydrate (JAN); Acalabrutinib maleate monohydrate; Calquence (TN) |
(P) unclassified |
| D12837 |
Risovalisib mesilate hydrate (JAN); Risovalisib mesylate dihydrate; Haizexin (TN) |
(P) unclassified |
| D12963 |
Macitentan and tadalafil; Opsynvi (TN); Yuvanci (TN) |
(CI,P) unclassified |
| D13026 |
Atogepant hydrate (JAN); Aquipta (TN) |
(P) CYP inhibition: CYP3A4 |
| D13231 |
Dimdazenil (INN) |
(P) unclassified |
